Neumora Therapeutics, Inc.

Ownership Transactions Reported by 17 Insiders

Symbol
NMRA on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
490 Arsenal Way, Suite 200, Watertown, MA

Insiders trading volume in the past year

Neumora Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Amgen Inc 10%+ Owner $424M Sep 19, 2023
Fmr Llc Other* $67.4M Sep 19, 2023
Kristina Burow Director, 10%+ Owner $66.5M +$5M +8.13% Oct 27, 2025
ARCH Venture Partners XII, LLC 10%+ Owner $66.4M +$5M +8.15% Oct 27, 2025
ARCH Venture Partners X, LLC 10%+ Owner $66.4M +$5M +8.15% Oct 27, 2025
Paul L. Berns Title: Chief Executive Officer and Chairman of the Board, Director $12.8M -$23.5K -0.18% May 28, 2025
Henry O. Gosebruch President & CEO, Director $7.07M Feb 14, 2024
Carol Y. Suh Chief Operating Officer $4.49M Feb 14, 2024
Robert A. Lenz Head of R&D $517K -$9.38K -1.78% Feb 18, 2025
Matthew K. Fust Director $342K May 28, 2025
David Piacquad Director $241K May 28, 2025
Alaa Halawa Director $241K May 28, 2025
Maykin Ho Director $241K May 28, 2025
Joshua Pinto President $166K -$13.5K -7.5% May 28, 2025
Daljit Singh Aurora Title: Chief Operating and Development Officer $162K -$321K -66.5% Nov 11, 2025
Michael Lee Milligan Title: Chief Financial Officer & Principal Accounting Officer $38.1K -$3.35K -8.09% May 28, 2025
Jason Duncan Title: Chief Legal and Administrative Officer May 28, 2025

Recent Insider Transactions by Companies or Individuals for Neumora Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.